✦ LIBER ✦

Secuential hemodynamic effects of terlipressin in patients with cirrhosis

✍ Scribed by D. Alvarez; L.E. Albornoz; J.C. Bandi; A.G. Villamil; O. Galdame; J.P. Roca; A.C. Gadano

Book ID: 119527019
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 310 KB
Volume: 34
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(01)81064-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of terlipressin on systemic, hep

Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis

✍ Yoshiyuki Narahara; Hidenori Kanazawa; Yasuhiko Taki; Yuu Kimura; Masanori Atsuk 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB

Hemodynamic effects of a combination of

Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis

✍ Wui-Chiang Lee; Han-Chieh Lin; Ying-Ying Yang; Ming-Chih Hou; Fa-Yauh Lee; Full- 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 114 KB

Hemodynamic and metabolic effects of ter

Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselectiveβ-blocker

✍ Florence Vachiery; Richard Moreau; Adrian Gadano; Song Yang; Phillippe Sogni; An 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 523 KB

Effects of somatostatin, terlipressin an

Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis

✍ GEORGIOS KALAMBOKIS; MICHALIS ECONOMOU; KOSTA PARASKEVI; PAPADIMITRIOU KONSTANTI 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

210 Effects of somatostatin, terlipressi

210 Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Bacterial translocation attenuates the s

Bacterial translocation attenuates the systemic hemodynamic improvement produced by terlipressin in patients with cirrhosis

✍ Georgios N. Kalambokis; Athanasia Mouzaki; Maria Rodi; Konstantinos Pappas; Epam 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB 👁 1 views

I can hardly share the passionate enthusiasm of Breuhahn et al. for the ''dramatic'' improvements in understanding of molecular pathogenesis of hepatocellular carcinoma (HCC) and the claim for ''further rationally designed clinical trials based on molecular evidence''. 1 Among the causes of HCC, the